Susquehanna International Group, LLP Kura Oncology, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$18.57 - $23.23 $185,700 - $232,300	-10,000 Reduced 30.96%	22,300 $435,000
Q2 2024 Aug 15, 2024	SELL	$17.53 - $22.98 $757,296 - $992,736	-43,200 Reduced 57.22%	32,300 $665,000
Q1 2024 May 07, 2024	BUY	$13.42 - $23.53 $727,364 - $1.28 Million	54,200 Added 254.46%	75,500 $1.61 Million
Q4 2023 Feb 14, 2024	SELL	$7.58 - $14.38 $501,796 - $951,956	-66,200 Reduced 75.66%	21,300 $306,000
Q3 2023 Nov 14, 2023	SELL	$8.44 - $11.86 $257,419 - $361,730	-30,500 Reduced 25.85%	87,500 $797,000
Q2 2023 Aug 11, 2023	BUY	$9.62 - $13.99 $1.14 Million - $1.65 Million	118,000 New	118,000 $1.25 Million
Q4 2022 Feb 14, 2023	BUY	$11.23 - $16.9 $235,830 - $354,899	21,000 Added 106.6%	40,700 $505,000
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $76,864 - $124,480	6,400 Added 48.12%	19,700 $269,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.